This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1177/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33613096
rdf:type
wikibase:Item
schema:description
2017년 논문 2017 nî lūn-bûn tudományos cikk articol științific bilimsel makale научни чланак artigo científico 2017年論文 научна статия 2017年论文 article scientific artigo científico (publicado na 2017) سائنسی مضمون teaduslik artikkel 2017 թվականի ապրիլին հրատարակված գիտական հոդված บทความทางวิทยาศาสตร์ 2017年論文 wetenschappelijk artikel vědecký článek article científic наукова стаття, опублікована у квітні 2017 2017年论文 wissenschaftlicher Artikel מאמר מדעי 2017年论文 مقالهٔ علمی vitenskapelig artikkel scientific article naučni članak επιστημονικό άρθρο 2017年論文 2017年论文 artículu científicu espublizáu en 2017 tieteellinen artikkeli articolo scientifico artikulong pang-agham مقالة علمية ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel (udgivet 2017) 2017年の論文 vedecký článok vetenskaplig artikel vitskapeleg artikkel мақолаи илмӣ 2017年論文 научная статья artigo científico (publicado na 2017) 2017年论文 2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած мақолаи илмӣ bài báo khoa học artykuł naukowy სამეცნიერო სტატია 2017年论文 artículo científico publicado en 2017 2017年論文 scienca artikolo artikull shkencor mokslinis straipsnis научни чланак article scientifique (publié 2017)
p:P577
wds:Q33613096-70E4C121-9A23-4643-B028-AF141C42836B
wdt:P577
2017-04-12T00:00:00Z
p:P2860
wds:Q33613096-309C41EA-BA93-4547-BCEF-F00C3C9780C2 wds:Q33613096-359F6CE1-6224-4722-834F-E091B7E70FD9 wds:Q33613096-4B07B7DB-86CC-4136-83B7-8A8F793F9166 wds:Q33613096-0AF28C75-BC33-4E31-8AB3-85567B3B7E9F wds:Q33613096-16208E5D-A735-49EF-8DCC-74D01F3C4A82 wds:Q33613096-F1E6E54E-363D-40AE-9A82-0D4C1864ED7B wds:Q33613096-EC09A24B-E089-4770-883C-1F8965AD1BA7 wds:Q33613096-ED6FC3FE-FC78-45AD-B50D-B3FEB97BA96C wds:Q33613096-EF50448A-2CB2-45C7-83BF-6623826E6416 wds:Q33613096-64A83510-4EFC-46B1-AB7D-C141EDBA90D0 wds:Q33613096-6D565200-B4DA-4950-B1A1-AEC75ADDDFA1 wds:Q33613096-7156648F-3895-4B8C-83EE-0037CB5A3A9A wds:Q33613096-4C8CA82A-4ABB-46C7-BE69-A80357F9F73E wds:Q33613096-9B7299B8-E2CC-4838-9DBE-D567D25CF676 wds:Q33613096-AA14F6EA-8D77-455B-BF84-31A11764C163 wds:Q33613096-CEFC0787-5519-4C3C-9360-AED0635B0DFD wds:Q33613096-74EAFDB1-01A1-45CB-9CCD-2C9FF5D1C78A wds:Q33613096-975E5F02-0FF6-4C82-893E-3B074A726F4A
wdt:P2860
wd:Q28255668 wd:Q38947432 wd:Q48493942 wd:Q30886623 wd:Q57073311 wd:Q37122242 wd:Q85947413 wd:Q43096111 wd:Q35798972 wd:Q40593214 wd:Q48714324 wd:Q26751073 wd:Q35827906 wd:Q34550423 wd:Q31044111 wd:Q37510442 wd:Q48192990 wd:Q31127872
p:P2093
wds:Q33613096-EFB3E8AC-8954-415B-936B-0E1E9849781B
wdt:P2093
Hans-Klaus Goischke
rdfs:label
Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues
skos:prefLabel
Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues
schema:name
Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues
p:P1476
wds:Q33613096-53602915-D1DE-4554-865C-97E27C1D5DB0
wdt:P1476
Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues
p:P304
wds:Q33613096-D11F11E2-C83E-44F5-9015-03EA373B8E8F
wdt:P304
2055217317704450
p:P31
wds:Q33613096-9338B893-3BCB-4652-9B2C-105E76FD9C78
wdt:P31
wd:Q13442814
p:P921
wds:Q33613096-F794EB20-28C3-449A-82C1-09E595FFDBA5
wdt:P921
wd:Q6849688
p:P698
wds:Q33613096-505E3F1E-3762-40EF-A1BF-AF444C2189A2
wdtn:P698
n11:28607758
wdt:P698
28607758
p:P1433
wds:Q33613096-9A50B0B1-C225-4E0F-8F46-81BCDE7E2909
wdt:P1433
wd:Q27726873
p:P433
wds:Q33613096-FDE9A7E5-0DB6-4116-B1D9-F0FEAD8283CF
p:P478
wds:Q33613096-2CD5406B-6E0D-463F-B967-D3FBBE6AF774
wdt:P433
2
wdt:P478
3
p:P356
wds:Q33613096-5103A29F-FCCE-457E-9126-8182DAF154BC
wdtn:P356
n10:2055217317704450
wdt:P356
10.1177/2055217317704450
p:P8608
wds:Q33613096-36A98337-9583-4D4C-B4F2-D3387B95DD33
wdt:P8608
release_4mjiq6tcnjfajgtz2d4bpjuoo4
p:P932
wds:Q33613096-BCFECCA0-5A0B-492C-BD37-FCD768616D9F
wdt:P932
5408503